Cervical cancer trends in the United States: A 35-year population-based analysis

Journal of Women's Health

Volumn 21, Issue 10, 2012, Pages 1031-1037

  Adegoke, Olusola ^a   Kulasingam, Shalini ^a   Virnig, Beth ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; SEER PROGRAM; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84867206488     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3385     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
3. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review 1975-2008. Bethesda, MD: National Cancer Institute, 2011.
4. Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control 2009;20:1129-1138.
5. Nelson W, Moser RP, Gaffey A, Waldron W. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: Data from the 2005 health information national trends survey (HINTS). J Womens Health 2009;18:1759-1768.
6. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study. Gynecol Oncol 2000;78:97-105.
7. Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice. Lancet Oncol 2011;12: 663-672.
8. Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer 2007;7:164.
9. Fisher JW, Brundage SI. The challenge of eliminating cervical cancer in the United States: A story of politics, prudishness, and prevention. Women Health 2009;49:246-261.
10. Wang SS, Carreon JD, Gomez SL, Devesa SS. Cervical cancer incidence among 6 Asian ethnic groups in the United States, 1996 through 2004. Cancer 2010;116:949-956.
11. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-1044.
12. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;86:429-435.
13. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
14. U.S. Preventive Services Task Force. Screening for cervical cancer: Recommendations and rationale. Am J Nurs 2003;103:101-102, 105-106, 108-109.
15. Percy C, Fritz A, Jack A, et al. International classification of diseases for oncology (ICD-O), 3rd ed. Geneva: World Health Organization, 2000.
16. Berg JW, Shottenfeld D, Fraumeni J Jr, eds. Morphologic classification of human cancer. In: Shottenfeld D, Fraumeni J Jr, eds. Morphologic classification of human cancer, 2nd ed. New York: Oxford University Press, 2006.
17. Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices among women in rural and urban areas of the united states. J Public Health Manag Pract 2009;15:200-209.
18. Khan K, Curtis CR, Ekwueme DU, et al. Preventing cervical cancer: Overviews of the National Breast and Cervical Cancer Early Detection Program and 2 U.S. immunization programs. Cancer 2008;113(Suppl 10):3004-3012.
19. Tabnak F, Muller HG, Wang JL, Zhang W, Howell LP. Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women. Cancer Causes Control 2010;21:411-420.
20. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in theUnited States, 1998-2002.ObstetGynecol 2007;109:360-370.
21. Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. relation to incidence and survival. Cancer 2005;103:1258-1264.
22. Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D. The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecol Oncol 2009;114:360-364.
23. Katki HA, Wentzensen N. How might HPV testing be integrated into cervical screening? Lancet Oncol 2012;13:8-10.
24. Sigurdsson K. The Icelandic and Nordic cervical screening programs: Trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 1999;78:478-485.
25. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
26. Castle PE, Fetterman B, Akhtar I, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol 2009;114:365-369.
27. Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models. Cancer Epidemiol Biomarkers Prev 2009;18:792-800.
28. Vinh-Hung V, Bourgain C, Vlastos G, et al. Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer 2007;7:164.
29. Russell-Briefel R, Ezzati T, Perlman J. Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54 years, United States, 1971-80. Am J Public Health 1985;75:1173-1176.
30. Piccinino LJ, Mosher WD. Trends in contraceptive use in the united states: 1982-1995. Fam Plann Perspect 1998;30: 4-10, 46.
31. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-1056.